Kai Zhang1, Song Zhao1, Qing Wang2, Hsin-Sheng Yang2, Jiang Zhu3, Rong Ma4. 1. Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China. 2. Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, USA. 3. Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China. drjiangzhu@hotmail.com. 4. Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China. marongw2000@163.com.
Abstract
BACKGROUND: Intraductal breast cancer is generally difficult to diagnose because of a lack of an efficient method for detection. The purpose of this study was to reveal and validate the differential expression of microRNAs (miRNAs) in nipple discharge from intraductal papilloma patients and identify miRNAs as novel potential biomarkers for primary breast cancer. METHODS: Nipple discharge samples were collected from three intraductal carcinoma breast cancer patients and three intraductal papilloma patients. The initial screening of miRNA expression was performed with an Axon GenePix 4000B microarray scanner using a novel approach to label miRNAs. The expression levels of the miRNAs selected from the initial screening were further examined by quantitative real-time polymerase chain reaction (qRT-PCR) in 21 validation samples (8 carcinomas and 13 benign tumors). An independent t test was used to detect significant correlations between the miRNA expression levels and breast cancer. RESULTS: Microarray profiling demonstrated that three miRNAs were markedly up-regulated and three miRNAs were down-regulated in the intraductal carcinoma breast cancer patients compared to the papilloma group. The qRT-PCR analysis further verified that four miRNAs (miR-4484, miR-K12-5-5p, miR-3646, and miR-4732-5p) might serve as potential tumor biomarkers for breast cancer detection. CONCLUSION: The novel approach of using a microarray scanner is applicable for studying biomarkers in nipple discharge containing small amounts of miRNA. miRNAs could serve as potential tumor biomarkers that can assist in breast cancer screening. Up-regulation of miR-4484, miR-K12-5-5p, and miR-3646 in nipple discharge may be a predictor of malignant breast cancer.
BACKGROUND: Intraductal breast cancer is generally difficult to diagnose because of a lack of an efficient method for detection. The purpose of this study was to reveal and validate the differential expression of microRNAs (miRNAs) in nipple discharge from intraductal papillomapatients and identify miRNAs as novel potential biomarkers for primary breast cancer. METHODS: Nipple discharge samples were collected from three intraductal carcinoma breast cancerpatients and three intraductal papillomapatients. The initial screening of miRNA expression was performed with an Axon GenePix 4000B microarray scanner using a novel approach to label miRNAs. The expression levels of the miRNAs selected from the initial screening were further examined by quantitative real-time polymerase chain reaction (qRT-PCR) in 21 validation samples (8 carcinomas and 13 benign tumors). An independent t test was used to detect significant correlations between the miRNA expression levels and breast cancer. RESULTS: Microarray profiling demonstrated that three miRNAs were markedly up-regulated and three miRNAs were down-regulated in the intraductal carcinoma breast cancerpatients compared to the papilloma group. The qRT-PCR analysis further verified that four miRNAs (miR-4484, miR-K12-5-5p, miR-3646, and miR-4732-5p) might serve as potential tumor biomarkers for breast cancer detection. CONCLUSION: The novel approach of using a microarray scanner is applicable for studying biomarkers in nipple discharge containing small amounts of miRNA. miRNAs could serve as potential tumor biomarkers that can assist in breast cancer screening. Up-regulation of miR-4484, miR-K12-5-5p, and miR-3646 in nipple discharge may be a predictor of malignant breast cancer.
Authors: Molly C Carney; Andrij Tarasiuk; Susan L DiAngelo; Patricia Silveyra; Abigail Podany; Leann L Birch; Ian M Paul; Shannon Kelleher; Steven D Hicks Journal: Pediatr Res Date: 2017-05-24 Impact factor: 3.756
Authors: Qiang Li; Yao Liu; Jiajia Bai; Song Zhao; Yawen Wang; Arzoo Shabbir; Kai Zhang; Fan Jiang; Jiang Zhu; Rong Ma; Jianli Wang Journal: BMC Womens Health Date: 2022-02-05 Impact factor: 2.809
Authors: Ya-Wen Wang; Song Zhao; Xun-Yi Yuan; Yao Liu; Kai Zhang; Jianli Wang; Jiang Zhu; Rong Ma Journal: J Cell Mol Med Date: 2019-01-31 Impact factor: 5.310
Authors: Cathy B Moelans; Susana I S Patuleia; Carla H van Gils; Elsken van der Wall; Paul J van Diest Journal: Int J Mol Sci Date: 2019-11-19 Impact factor: 5.923